Botswana vs Spain: Access to anti-retroviral drugs, male
Botswana
92.0%
in 2024
Spain
91.0%
in 2022
Botswana rank
11th
Spain rank
12th
Access to anti-retroviral drugs, male over time
- Botswana
- Spain
How they compare
Botswana currently reports 92.0% against 91.0% in Spain, a difference of 1.0%.
Across all 23 years both countries report, Spain has been ahead every year.
Botswana ranks 11th and Spain ranks 12th of 141 countries.
Spain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Botswana | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.1% | 41.7% | 22.6% | Spain |
| 2010s | 64.8% | 73.4% | 8.6% | Spain |
| 2020s | 86.0% | 88.7% | 2.7% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Botswana or Spain?
- Botswana, at 92.0% against 91.0% in Spain as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Botswana and Spain?
- 1.0%, with Botswana ahead.
- How many years of comparable data are there for Botswana and Spain?
- 23 years are reported by both, from 2000 to 2022.
- How do Botswana and Spain rank globally for access to anti-retroviral drugs, male?
- Botswana ranks 11th and Spain ranks 12th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.